Medtronic PLC vs UiPath Inc — how do they compare? Medtronic PLC trades at $82.23 (market cap $106.61B), while UiPath Inc trades at $11.92 (market cap $6.30B). The key difference: Medtronic PLC is far larger — about 16.9× UiPath Inc's market cap, and Medtronic PLC pays a 3.46% dividend while UiPath Inc pays none. Which is the better fit depends on your goals.
| MDT | PATH | |
|---|---|---|
Market Cap | $106.61B | $6.30B |
Sector | Health | Technology |
52-Week High | $105.35 | $19.29 |
52-Week Low | $73.75 | $9.38 |
Enterprise Value | $125.36B | $5.08B |
Dividend Yield | 3.46% | — |
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →